This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignees: Schering Corporation, New York Stem Cell Foundation, Inc.. Active years: 2001-2026.
Company Filing History:
Years Active: 2001-2026
Title: The Innovations of Frederick J Monsma
Introduction
Frederick J Monsma is a notable inventor based in Summit, NJ (US). He has made significant contributions to the field of biochemistry, particularly in the development of histamine receptor antibodies. With a total of 4 patents, Monsma's work has implications for treating various medical conditions.
Latest Patents
Monsma's latest patents focus on the isolated mammalian histamine receptor. The first patent provides an isolated mammalian histamine receptor, along with isolated or recombinant nucleic acids and recombinant vectors encoding the same. It also includes host cells that comprise these nucleic acids and vectors, as well as methods for producing the receptor using these host cells. This invention further offers antibodies and antigen-binding fragments that specifically bind to the receptor, which are useful for treating medical conditions caused or mediated by histamine. Additionally, screening methods for identifying specific agonists and antagonists of the mammalian histamine receptor are included.
Career Highlights
Monsma is associated with Schering Corporation, where he has been able to apply his innovative ideas in a collaborative environment. His work has contributed to advancements in medical treatments and therapeutic approaches.
Collaborations
Some of his notable coworkers include Shelby P Umland and Suke Wang, who have likely contributed to the collaborative efforts in his research and development projects.
Conclusion
Frederick J Monsma's contributions to the field of biochemistry through his patents on histamine receptors highlight his innovative spirit and dedication to improving medical treatments. His work continues to influence the scientific community and offers potential solutions for various health issues.